CVE:LXGLexagene Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Lexagene Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.79 -0.09 (-10.23 %) (As of 06/2/2020 04:00 PM ET) Add Compare Share Today's RangeC$0.79Now: C$0.79▼C$0.8950-Day RangeC$0.52MA: C$0.76▼C$0.8652-Week RangeC$0.43Now: C$0.79▼C$1.00Volume291,721 shsAverage Volume241,486 shsMarket CapitalizationC$67.69 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlinesSocial Media LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of automated pathogen detection platform in the life sciences and diagnostics industries. The company's platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. Its technology aims to transform the way organizations prevent and diagnose disease in various markets, such as food safety, veterinary diagnostics, water quality monitoring, aquaculture pathogen surveillance, and more. The company is headquartered in Beverly, Massachusetts.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Lexagene. Previous Next 2.5 Community Rank Outperform VotesLexagene has received 51 “outperform” votes. (Add your “outperform” vote.)Underperform VotesLexagene has received 52 “underperform” votes. (Add your “underperform” vote.)Community SentimentLexagene has received 50.49% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Lexagene and other stocks. Vote “Outperform” if you believe LXG will outperform the S&P 500 over the long term. Vote “Underperform” if you believe LXG will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldLexagene does not currently pay a dividend.Dividend GrowthLexagene does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Lexagene insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Lexagene is -6.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Lexagene is -6.93, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioLexagene has a P/B Ratio of 18.37. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Diagnostics & Research Sub-IndustryN/A SectorMedical Current SymbolCVE:LXG Previous Symbol CUSIPN/A CIKN/A Webwww.lexagene.com Phone800-215-1824Debt Debt-to-Equity Ratio51.35 Current Ratio14.22 Quick Ratio12.82Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.03 per share Price / Cash Flow26.06 Book ValueC$0.04 per share Price / Book18.37Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees20 Outstanding Shares85,689,000Market CapC$67.69 million Next Earnings DateN/A OptionableNot Optionable TSXV:LXG Rates by TradingView Receive LXG News and Ratings via Email Sign-up to receive the latest news and ratings for LXG and its competitors with MarketBeat's FREE daily newsletter. Lexagene (CVE:LXG) Frequently Asked Questions How has Lexagene's stock been impacted by COVID-19 (Coronavirus)? Lexagene's stock was trading at C$0.73 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, LXG shares have increased by 8.2% and is now trading at C$0.79. View which stocks have been most impacted by Coronavirus. Has Lexagene been receiving favorable news coverage? Press coverage about LXG stock has trended somewhat negative on Tuesday, according to InfoTrie Sentiment Analysis. InfoTrie ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Lexagene earned a daily sentiment score of -1.6 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutLexagene. Who are some of Lexagene's key competitors? Some companies that are related to Lexagene include Volpara Health Tech (VHT), Profound Medical (PRN), Renalytix Ai (RENX), Akumin (AKU), Exagen (XGN), Yourgene Health (YGEN), Senseonics (SENS), Palatin Technologies (PTN), MaxCyte (MXCT), Oncosil Medical (OSL), Oncimmune (ONC), Genedrive (GDR), SQI Diagnostics (SQD), BARD1 Life Sciences (BD1) and Sernova (SVA). View all competitors. What other stocks do shareholders of Lexagene own? Based on aggregate information from My MarketBeat watchlists, some companies that other Lexagene investors own include HIVE Blockchain Technologies (HIVE), EQT (EQT), Antibe Therapeutics (ATE), AzurRx BioPharma (AZRX), Bellicum Pharmaceuticals (BLCM), Inovio Pharmaceuticals (INO), Kirkland Lake Gold (KL), Know Labs (KNWN), Micron Technology (MU) and PING AN INS GRP/S (PNGAY). Who are Lexagene's key executives? Lexagene's management team includes the following people: Dr. John F. Regan, Founder, Chairman & CEOMr. Darrel M. Rebeck, Pres & DirectorMr. Jeffrey Mitchell, Chief Financial OfficerMr. Allan Fabbro, VP of Corp. Devel. What is Lexagene's stock symbol? Lexagene trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LXG." How do I buy shares of Lexagene? Shares of LXG and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Lexagene's stock price today? One share of LXG stock can currently be purchased for approximately C$0.79. How big of a company is Lexagene? Lexagene has a market capitalization of C$67.69 million. Lexagene employs 20 workers across the globe. What is Lexagene's official website? The official website for Lexagene is www.lexagene.com. How can I contact Lexagene? The company can be reached via phone at 800-215-1824. This page was last updated on 6/2/2020 by MarketBeat.com Staff
